Acadia Pharmaceuticals Inc (ACAD)

Short-Term Debt

$14.31M

Quarterly · Period ending: · USD

ACAD logo

ACAD Short-Term Debt

Latest reported$14.31M
ACAD Quarterly Short-Term Debt ($3.24M → $14.31M)
High-resolution chart · PNG

ACAD short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Acadia Pharmaceuticals Inc Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
14,307,000
11,791,000
11,633,000
11,783,000
11,693,000
11,372,000
9,958,000
8,949,000
10,470,000
10,453,000
9,405,000
9,031,000
9,058,000
9,173,000
9,305,000
9,231,000
9,024,000
8,944,000
8,304,000
8,150,000
7,521,000
6,082,000
5,087,000
3,857,000
2,653,000
2,909,000
3,434,000
3,889,000
4,412,000
4,468,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,000
13,000
22,000
32,000
37,000
40,000
44,000
78,000
111,000
161,000
291,000
365,000
450,000
560,000
685,000
795,000
815,000
882,000
934,000
978,000
1,017,000
1,047,000
1,039,000
996,000
902,000
826,000
805,000
890,000
926,400
854,600
844,800
1,486,000
2,059,400
2,604,100
3,167,400
3,242,300
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.